Author | John Morris, MD | OncLive

Author | John Morris, MD


Dr. Morris on Lymphopenia as a Predictor of Survival in CRT-Treated NSCLC

September 30, 2015


John Morris, MD, professor of Medicine, co-director, Comprehensive Lung Cancer Center, associate director, UCCI Translational Research and Director, Experimental Therapeutics, University of Cincinnatti, discusses lymphopenia as a predictor of survival in chemoradiation-treated non–small cell lung cancer.